Glossary

Laboratory Investigation

The investigation stage that first asks whether the laboratory is the cause when a test result falls outside specification.

Details

To attribute an out-of-specification result to laboratory error, the error has to be identified and evidenced; where it cannot be identified, the investigation must widen to production. The corpus cites retest results accepted as passing without the root cause being found, laboratory causes named but not supported by documentation, and intermediate failures where no investigation was performed at all. What is examined is who approved the decision to invalidate the original result and when, and where the retest sample came from.

Related sections

Related terms

Real inspection findings

Findings from regulators' inspection documents in which this term appears.

  1. Our inspection revealed serious deviations, including but not limited to, inadequate oversight of original CGMP documents, deficient controls over computerized systems, insufficient laboratory investigations, and aborted chromatographic sequences.
    FDA · FDA Warning Letter · 2023-08-01
  2. Laboratory investigations for OOS intermediate batches are not conducted.
    FDA · FDA 483 · 2018-12-10
  3. Laboratory investigations were not conducted timely based on an identifiable trend or thoroughly to determine the root cause.
    FDA · FDA 483 · 2025-11-03
See 15 findings that mention this term

Source

21 CFR 211.192 Production record review; FDA Guidance for Industry, Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production (Level 2 revision, 2022-05, Docket FDA-1998-D-0019)